TGM7

gene
On this page

Also known as TGMZ

Summary

TGM7 (transglutaminase 7, HGNC:30790) is a protein-coding gene on chromosome 15q15.2, encoding Protein-glutamine gamma-glutamyltransferase Z (Q96PF1). Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.

Transglutaminases (TGM; EC 2.3.2.13) are a family of structurally and functionally related enzymes that stabilize protein assemblies through the formation of gamma-glutamyl-epsilon lysine crosslinks. For additional background information on transglutaminases, see TGM1 (MIM 190195).

Source: NCBI Gene 116179 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 123 total
  • MANE Select transcript: NM_052955

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30790
Approved symbolTGM7
Nametransglutaminase 7
Location15q15.2
Locus typegene with protein product
StatusApproved
AliasesTGMZ
Ensembl geneENSG00000159495
Ensembl biotypeprotein_coding
OMIM606776
Entrez116179

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron

ENST00000452443, ENST00000562372

RefSeq mRNA: 1 — MANE Select: NM_052955 NM_052955

CCDS: CCDS32213

Canonical transcript exons

ENST00000452443 — 13 exons

ExonStartEnd
ENSE000010459524329344943293631
ENSE000011473704327686243276995
ENSE000011473764327911743279277
ENSE000011473804327962543279951
ENSE000011473864328184443282086
ENSE000011473904328251743282620
ENSE000011473974328481443284952
ENSE000011474014328728043287457
ENSE000011474044328754143287669
ENSE000011474054329197943292097
ENSE000011474094329270943292954
ENSE000016004494330224143302255
ENSE000034659744327627143276614

Expression profiles

Bgee: expression breadth broad, 66 present calls, max score 85.02.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0023 / max 3.2212, expressed in 1 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1496020.00231

Top tissues by expression

217 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065585.02gold quality
oocyteCL:000002384.95gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.51gold quality
gingival epitheliumUBERON:000194975.17silver quality
left testisUBERON:000453370.95gold quality
gingivaUBERON:000182868.91silver quality
right testisUBERON:000453468.88gold quality
testisUBERON:000047367.88gold quality
spermCL:000001965.31gold quality
colonic epitheliumUBERON:000039763.38gold quality
gastrocnemiusUBERON:000138858.25gold quality
amniotic fluidUBERON:000017356.45gold quality
muscle of legUBERON:000138353.91gold quality
tonsilUBERON:000237250.25gold quality
cerebellar vermisUBERON:000472048.93gold quality
hindlimb stylopod muscleUBERON:000425248.60gold quality
mammalian vulvaUBERON:000099747.38gold quality
thymusUBERON:000237047.07gold quality
vaginaUBERON:000099646.48gold quality
bone marrow cellCL:000209246.24gold quality
esophagus mucosaUBERON:000246945.04gold quality
body of tongueUBERON:001187644.39gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
prostate glandUBERON:000236743.35gold quality
superior surface of tongueUBERON:000737143.31gold quality
tongueUBERON:000172342.94gold quality
lower lobe of lungUBERON:000894942.68silver quality
quadriceps femorisUBERON:000137742.59gold quality
epithelium of nasopharynxUBERON:000195142.29gold quality
myocardiumUBERON:000234942.20gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.28

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): EGR1

miRNA regulators (miRDB)

6 targeting TGM7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-570198.9769.541502
HSA-MIR-6818-3P98.5668.231307
HSA-MIR-505-5P97.0165.54778
HSA-MIR-103B95.5166.85441

Literature-anchored findings (GeneRIF, showing 1)

  • Then, using the most efficient peptide, Z3S, we established an in vitro assay system to assess enzymatic activity of TG7. (PMID:23876241)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotgm8ENSDARG00000097651
danio_reriotgm5lENSDARG00000098837
mus_musculusTgm7ENSMUSG00000079103
rattus_norvegicusTgm7ENSRNOG00000037203

Paralogs (8): TGM1 (ENSG00000092295), TGM5 (ENSG00000104055), F13A1 (ENSG00000124491), TGM3 (ENSG00000125780), TGM4 (ENSG00000163810), EPB42 (ENSG00000166947), TGM6 (ENSG00000166948), TGM2 (ENSG00000198959)

Protein

Protein identifiers

Protein-glutamine gamma-glutamyltransferase ZQ96PF1 (reviewed: Q96PF1)

Alternative names: Transglutaminase Z, Transglutaminase-7

All UniProt accessions (1): Q96PF1

UniProt curated annotations — full annotation on UniProt →

Function. Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.

Tissue specificity. Widely expressed.

Cofactor. Binds 1 Ca(2+) ion per subunit.

Similarity. Belongs to the transglutaminase superfamily. Transglutaminase family.

RefSeq proteins (1): NP_443187* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001102Transglutaminase_NDomain
IPR002931Transglutaminase-likeDomain
IPR008958Transglutaminase_CDomain
IPR013783Ig-like_foldHomologous_superfamily
IPR013808Transglutaminase_ASActive_site
IPR014756Ig_E-setHomologous_superfamily
IPR023608Transglutaminase_animalFamily
IPR036238Transglutaminase_C_sfHomologous_superfamily
IPR036985Transglutaminase-like_sfHomologous_superfamily
IPR038765Papain-like_cys_pep_sfHomologous_superfamily
IPR050779TransglutaminaseFamily

Pfam: PF00868, PF00927, PF01841

Enzyme classification (BRENDA):

  • EC 2.3.2.13 — protein-glutamine gamma-glutamyltransferase (BRENDA: 68 organisms, 476 substrates, 772 inhibitors, 122 Km, 49 kcat entries)

Substrate kinetics (BRENDA)

60 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.

SubstrateKm (mM)Measurements
PUTRESCINE0.035–9.6313
L-LYSINE2.9–15.86
N-CBZ-GLN-GLY12.83–59.55
HYDROXYLAMINE1.37–61.94
NALPHA-BENZYLOXYCARBONYL-L-GLN-GLY11.2–304
CASEIN0.006–0.0123
CBZ-GLN-GLY0.0169–5.93
CBZ-GLN-GLY-OH3.53–8.553
METHYLAMINE0.024–0.0613
MONODANSYLCADAVERINE0.01–0.0343
N-CARBOXYBENZOYL-L-GLUTAMINYL-GLYCINE0.0547–69.43
PENTYLAMINE0.0029–0.02033
Z-GLN-GLY1.8–11.63
ACETYL-ALPHAS1-CASEIN0.0029–0.00322
GTP0.0044–0.012

Catalyzed reactions (Rhea), 1 shown:

  • L-glutaminyl-[protein] + L-lysyl-[protein] = [protein]-L-lysyl-N(6)-5-L-glutamyl-[protein] + NH4(+) (RHEA:54816)

UniProt features (8 total): binding site 4, active site 3, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96PF1-F192.410.77

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 279; 338; 361

Ligand- & substrate-binding residues (4): 401; 403; 450; 455

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 27 (showing top): GOBP_PEPTIDE_CROSS_LINKING, TGANTCA_AP1_C, RGAGGAARY_PU1_Q6, MODULE_95, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, HMGIY_Q6, GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY, MODULE_163, MIR505_5P, GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN, NABA_ECM_REGULATORS, GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP, GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP, FOXM1_01

GO Biological Process (1): peptide cross-linking (GO:0018149)

GO Molecular Function (5): protein-glutamine gamma-glutamyltransferase activity (GO:0003810), metal ion binding (GO:0046872), protein binding (GO:0005515), transferase activity (GO:0016740), acyltransferase activity (GO:0016746)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein modification process1
aminoacyltransferase activity1
catalytic activity, acting on a protein1
cation binding1
binding1
catalytic activity1
transferase activity1

Protein interactions and networks

STRING

462 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TGM7PLEKHG5O94827507
TGM7KLHL6Q8WZ60487
TGM7KLHL7Q8IXQ5456
TGM7ZMYM3Q14202453
TGM7LHFPL5Q8TAF8415
TGM7KRTAP19-7Q3SYF9370
TGM7DMTNQ08495350
TGM7GRAMD2AQ8IUY3338
TGM7DCST1Q5T197324
TGM7LRP1BQ9NZR2323
TGM7SFTA3P0C7M3323
TGM7VMO1Q7Z5L0320
TGM7CD47Q08722318
TGM7OR6X1Q8NH79311
TGM7OR13J1Q8NGT2305

IntAct

65 interactions, top by confidence:

ABTypeScore
TGM7PPCDCpsi-mi:“MI:0915”(physical association)0.560
PPCDCTGM7psi-mi:“MI:0915”(physical association)0.560
KCTD1TGM7psi-mi:“MI:0915”(physical association)0.560
FRS3TGM7psi-mi:“MI:0915”(physical association)0.560
TNXBTGM7psi-mi:“MI:0915”(physical association)0.560
ARID5ATGM7psi-mi:“MI:0915”(physical association)0.560
SPATA18TGM7psi-mi:“MI:0915”(physical association)0.560
TGM7psi-mi:“MI:0915”(physical association)0.560
HNRNPFTGM7psi-mi:“MI:0915”(physical association)0.560
QARS1TGM7psi-mi:“MI:0915”(physical association)0.560
SDSTGM7psi-mi:“MI:0915”(physical association)0.560
KRT39TGM7psi-mi:“MI:0915”(physical association)0.560
GEMTGM7psi-mi:“MI:0915”(physical association)0.560
TGM7TSSK3psi-mi:“MI:0915”(physical association)0.560
PRKAB2TGM7psi-mi:“MI:0915”(physical association)0.560
TGM7UNKLpsi-mi:“MI:0915”(physical association)0.560
LNX1TGM7psi-mi:“MI:0915”(physical association)0.560
TGM7LAMTOR3psi-mi:“MI:0915”(physical association)0.560
SAXO4TGM7psi-mi:“MI:0915”(physical association)0.560
SPRY1TGM7psi-mi:“MI:0915”(physical association)0.560
HOXA1TGM7psi-mi:“MI:0915”(physical association)0.560
TGM7HGSpsi-mi:“MI:0914”(association)0.350
TGM7KCTD1psi-mi:“MI:0915”(physical association)0.000
FRS3TGM7psi-mi:“MI:0915”(physical association)0.000
TNXBTGM7psi-mi:“MI:0915”(physical association)0.000
TGM7ARID5Apsi-mi:“MI:0915”(physical association)0.000

BioGRID (35): TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), PPP1R32 (Two-hybrid), TSSK3 (Two-hybrid), SPATA18 (Two-hybrid), SPRY1 (Two-hybrid), GEM (Two-hybrid), TNXB (Two-hybrid)

ESM2 similar proteins: A0A1W2PQ27, A0A1W2PQ64, A0A1W2PQC6, A0A1W2PQD8, A0A1W2PQJ5, A0A1W2PR75, A2AV36, A4QN59, A6QQV6, D4A1F2, F1RA39, G5E8F4, J9SQF3, O00142, O42868, O55239, O95050, O95932, O97972, P0CR76, P0CR77, P10938, P40261, P40936, P53538, Q01841, Q22453, Q32LP9, Q4R7D0, Q566Y1, Q5M9G7, Q5RFR7, Q5U4E8, Q5XG58, Q62160, Q6C195, Q6CQ61, Q6DE00, Q6FMU7, Q6PCI6

Diamond homologs: A6QP57, D4A5U3, O08619, O43548, O46510, O95932, P00488, P08587, P16452, P21980, P21981, P22735, P22758, P23606, P49221, P51176, P52181, P52183, Q01841, Q05187, Q08188, Q08189, Q8BH61, Q8BZH1, Q96PF1, Q99041, Q9D7I9, Q9GLK0, Q9JLF6, Q9WVJ6, P49222, P12260

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

123 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance109
Likely benign10
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2142 predictions. Top by Δscore:

VariantEffectΔscore
15:43276610:CAAGG:Cacceptor_gain1.0000
15:43276860:A:ACdonor_gain1.0000
15:43276860:ACT:Adonor_gain1.0000
15:43276860:ACTC:Adonor_gain1.0000
15:43276861:C:CAdonor_gain1.0000
15:43276861:CT:Cdonor_gain1.0000
15:43276861:CTC:Cdonor_gain1.0000
15:43276861:CTCC:Cdonor_gain1.0000
15:43276861:CTCCT:Cdonor_gain1.0000
15:43276863:C:CAdonor_gain1.0000
15:43276993:CAC:Cacceptor_gain1.0000
15:43276993:CACCT:Cacceptor_loss1.0000
15:43276994:ACCTG:Aacceptor_loss1.0000
15:43276997:T:Aacceptor_loss1.0000
15:43276998:G:Cacceptor_gain1.0000
15:43279173:T:TAdonor_gain1.0000
15:43279174:C:Adonor_gain1.0000
15:43279623:AC:Adonor_gain1.0000
15:43279624:CC:Cdonor_gain1.0000
15:43281853:A:ACdonor_gain1.0000
15:43281854:C:CCdonor_gain1.0000
15:43282511:A:ACdonor_gain1.0000
15:43282512:C:CCdonor_gain1.0000
15:43282513:TCA:Tdonor_loss1.0000
15:43282515:A:ACdonor_gain1.0000
15:43282516:C:Adonor_loss1.0000
15:43282516:C:CCdonor_gain1.0000
15:43282516:CCA:Cdonor_gain1.0000
15:43282617:GTTC:Gacceptor_gain1.0000
15:43282618:TTC:Tacceptor_gain1.0000

AlphaMissense

4669 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
15:43287368:A:CS259R0.993
15:43287368:A:TS259R0.993
15:43287370:T:GS259R0.993
15:43293533:G:TR37S0.987
15:43284909:G:CF303L0.985
15:43284909:G:TF303L0.985
15:43284911:A:GF303L0.985
15:43282596:G:CC343W0.983
15:43282614:G:CF337L0.983
15:43282614:G:TF337L0.983
15:43282616:A:GF337L0.983
15:43282556:A:GW357R0.982
15:43282556:A:TW357R0.982
15:43292095:C:GD148H0.982
15:43284925:C:GR298P0.981
15:43282607:A:GW340R0.980
15:43282607:A:TW340R0.980
15:43282042:C:AG385W0.978
15:43287547:A:CS227R0.978
15:43287547:A:TS227R0.978
15:43287549:T:GS227R0.978
15:43282598:A:GC343R0.977
15:43284919:A:TV300D0.977
15:43282071:C:TG375D0.976
15:43282576:A:GL350P0.976
15:43282585:C:GR347P0.976
15:43293532:C:GR37P0.975
15:43287299:G:CF282L0.974
15:43287299:G:TF282L0.974
15:43287301:A:GF282L0.974

dbSNP variants (sampled 300 via entrez): RS1000048500 (15:43291517 T>C), RS1000199967 (15:43303853 A>G), RS1000223377 (15:43297683 G>A), RS1000273599 (15:43304090 G>A,T), RS1000526789 (15:43298944 A>C,G,T), RS1000587307 (15:43302338 C>G,T), RS1000603027 (15:43292721 G>T), RS1000949259 (15:43292903 C>A,G,T), RS1001057702 (15:43302623 G>A,T), RS1001201600 (15:43296299 C>T), RS1001266924 (15:43290281 A>G), RS1001426293 (15:43302847 T>C), RS1001481252 (15:43277674 A>G,T), RS1001638409 (15:43277772 T>C), RS1001649116 (15:43280007 G>A,T)

Disease associations

OMIM: gene MIM:606776 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation, decreases methylation1
Fulvestrantaffects cotreatment, increases methylation1
Acetaminophendecreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation1
Coalincreases abundance, increases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.